0
0
0
Patient Right to Shop Act
12/15/2023, 4:07 PM
Summary of Bill S 1374
The Patient Right to Shop Act, also known as Bill 118 s 1374, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to give patients more control over their healthcare costs by allowing them to shop around for medical services and compare prices before receiving treatment.
Under this proposed law, healthcare providers would be required to provide patients with information on the cost of medical services, including the price of procedures, tests, and medications. This would allow patients to make more informed decisions about their healthcare and potentially save money by choosing lower-cost options.
Additionally, the Patient Right to Shop Act would establish a database of healthcare prices that patients could access to compare costs between different providers. This database would help patients find the best value for their healthcare needs and promote competition among healthcare providers to offer more affordable services. Overall, supporters of the Patient Right to Shop Act believe that it will empower patients to take control of their healthcare costs and make more informed decisions about their medical treatment. Critics, however, argue that the bill could lead to increased administrative burdens for healthcare providers and potentially limit access to care for some patients. As of now, the fate of the Patient Right to Shop Act is uncertain, but it is clear that the issue of healthcare cost transparency is an important one that will continue to be debated in Congress.
Under this proposed law, healthcare providers would be required to provide patients with information on the cost of medical services, including the price of procedures, tests, and medications. This would allow patients to make more informed decisions about their healthcare and potentially save money by choosing lower-cost options.
Additionally, the Patient Right to Shop Act would establish a database of healthcare prices that patients could access to compare costs between different providers. This database would help patients find the best value for their healthcare needs and promote competition among healthcare providers to offer more affordable services. Overall, supporters of the Patient Right to Shop Act believe that it will empower patients to take control of their healthcare costs and make more informed decisions about their medical treatment. Critics, however, argue that the bill could lead to increased administrative burdens for healthcare providers and potentially limit access to care for some patients. As of now, the fate of the Patient Right to Shop Act is uncertain, but it is clear that the issue of healthcare cost transparency is an important one that will continue to be debated in Congress.
Read the Full Bill
Current Status of Bill S 1374
Bill S 1374 is currently in the status of Bill Introduced since April 27, 2023. Bill S 1374 was introduced during Congress 118 and was introduced to the Senate on April 27, 2023. Bill S 1374's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 27, 2023
Bipartisan Support of Bill S 1374
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
6Democrat Cosponsors
4Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 1374
Primary Policy Focus
HealthAlternate Title(s) of Bill S 1374
Patient Right to Shop Act
Patient Right to Shop Act
A bill to prohibit group health plans and health insurance issuers from entering into contracts that would prevent or restrict patient access to drug pricing information otherwise available through consumer decision-support tools.
Comments
Sponsors and Cosponsors of S 1374
Latest Bills
Protecting America’s Orchardists and Nursery Tree Growers Act
Bill HR 8251April 15, 2026
Healthy Watersheds, Healthy Communities Act of 2026
Bill S 4234April 15, 2026
Consumer Data Privacy and Security Act of 2026
Bill S 4211April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-07 re: in-person collection of consumer debt".
Bill SJRES 162April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-05: Debt Collection and Consumer Reporting Practices Involving Invalid Nursing Home Debts".
Bill SJRES 159April 15, 2026
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
Bill SJRES 163April 15, 2026
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
Bill SJRES 161April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Compliance Bulletin 2016-03: Detecting and Preventing Consumer Harm From Production Incentives".
Bill SJRES 170April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-06: Unanticipated Overdraft Fee Assessment Practices".
Bill SJRES 169April 15, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2023-01: Unlawful Negative Option Marketing Practices".
Bill SJRES 160April 15, 2026



